Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02110994

Ligand	Ligand name	Chain	PDB	Tanimoto
BRF		A	1UUO	0.75
REW	(2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID	A	2REW	0.71
IMS	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	P	2OYU	0.71
MTK	MONTELUKAST	A	2NNI	0.7
IM8	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	P	2OYE	0.71
238		A	2PRH	0.79
DK1	5,7-DICHLORO-4-HYDROXYQUINOLINE-2-CARBOXYLIC ACID	A,B	1PBQ	0.77
SF2	5-CHLORO-1-(3-METHOXYBENZYL)-3-(PHENYLTHIO)-1H-INDOLE-2-CARBOXYLIC ACID	A,B	2Q6R	0.72
MMB	(2R,3E)-2-{4-[(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHOXY]BENZYL}-3-(PROPOXYIMINO)BUTANOIC ACID	A,C	2NPA	0.72
550	methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate	A,B	3EDZ	0.71
ZAA	(5-{3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}-2-phenyl-2H-1,2,3-triazol-4-yl)acetic acid	A	3BC5	0.7
GNI	(3-{4-[2-(2,4-DICHLORO-PHENOXY)-ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL-3-YL}-PHENYL)-ACETIC ACID	A,B	2J14	0.7
IMM	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	A,B	1PGF	0.7
IMM	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	A,B	1PGG	0.7
8PC	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	A,B	2OP1	0.71
8PC	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	A,B,C,D	3FNE	0.71
643	6-(4-{[3-(3,5-dichloropyridin-4-yl)-5-(1-methylethyl)isoxazol-4-yl]methoxy}-2-methylphenyl)-1-methyl-1H-indole-3-carboxylic acid	A	3FXV	0.73
900	N-(4-chlorophenyl)-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	A,B	3B8Q	0.7
QND	QUINALDIC ACID	A,B	1IDA	0.71
MR6	2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE	A,B	2QGE	0.7
205	2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID	A,B	2F8I	0.75
642	(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid	A,B	3EWJ	0.71
QUN	QUINACRINE	A,B	1JQE	0.71
2CS	3-[3-(TERT-BUTYLTHIO)-1-(4-CHLOROBENZYL)-5-(QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID	A,C,D,E	2Q7M	0.75
615	(1R,2S)-N~2~-hydroxy-1-{4-[(2-phenylquinolin-4-yl)methoxy]benzyl}cyclopropane-1,2-dicarboxamide	A,B	3E8R	0.73
BRE	2-BIPHENYL-4-YL-6-FLUORO-3-METHYL-QUINOLINE-4-CARBOXYLIC ACID	A	1D3G	0.75
570	2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID	A,D	1RDT	0.7
570	2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID	A,D	1FM9	0.7
IMN	INDOMETHACIN	A	2BXM	0.76
IMN	INDOMETHACIN	A	3FO7	0.76
IMN	INDOMETHACIN	A,B,C,D	1Z9H	0.76
IMN	INDOMETHACIN	A	2BXQ	0.76
IMN	INDOMETHACIN	A,B,C,D	4COX	0.76
IMN	INDOMETHACIN	A	2ALT	0.76
IMN	INDOMETHACIN	A	2OTH	0.76
IMN	INDOMETHACIN	A,B	2DM6	0.76
IMN	INDOMETHACIN	A	1S2A	0.76
IMN	INDOMETHACIN	A	2ZB8	0.76
IMN	INDOMETHACIN	A	3HWZ	0.76
IMN	INDOMETHACIN	A	2BXK	0.76
BPD	N-(M-TRIFLUOROMETHYLPHENYL) PHENOXAZINE-4,6-DICARBOXYLIC ACID	A	1DVY	0.74
03R	2-({6-{3-[AMINO(IMINO)METHYL]PHENOXY}-3,5-DIFLUORO-4-[(1-METHYL-3-PHENYLPROPYL)AMINO]-2-PYRIDINYL}OXY)BENZOIC ACID	H,L	2AEI	0.7
669	1-(5-CARBOXYPENTYL)-5-(2,6-DICHLOROBENZYLOXY)-1H-INDOLE-2-CARBOXYLIC ACID	A	1MZS	0.76
JTP	N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE	A,B	2DXS	0.71
3CS	3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4-IODOBENZYL)-5-(QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID	A,B,C,D,E,F	2Q7R	0.74
338	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	A,B	1U3R	0.74
UN9	N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE	A	2HBT	0.73
UN9	N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE	A	2HBU	0.73
HQU	3-HYDROXYQUINALDIC ACID	C,D	193D	0.79
YPA	(S)-3-(4-(2-CARBAZOL-9-YL-ETHOXY)-PHENYL)-2-ETHOXY-PROPIONIC ACID	A	1KNU	0.7